A detailed history of Centurion Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Centurion Wealth Management LLC holds 975 shares of LLY stock, worth $759,154. This represents 0.28% of its overall portfolio holdings.

Number of Shares
975
Previous 1,247 21.81%
Holding current value
$759,154
Previous $970 Million 10.93%
% of portfolio
0.28%
Previous 0.38%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $210,022 - $261,125
-272 Reduced 21.81%
975 $864 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $181,213 - $242,437
306 Added 32.52%
1,247 $970 Million
Q2 2023

Jul 21, 2023

SELL
$350.74 - $468.98 $350 - $468
-1 Reduced 0.11%
941 $441 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $310 - $364
-1 Reduced 0.11%
942 $324 Million
Q4 2022

Feb 23, 2023

BUY
$321.55 - $374.67 $303,221 - $353,313
943 New
943 $345 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Centurion Wealth Management LLC Portfolio

Follow Centurion Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centurion Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centurion Wealth Management LLC with notifications on news.